DOK7 Gene: Docking Protein 7

Key Regulator of Neuromuscular Junction Formation and Congenital Myasthenic Syndromes

Gene Information Card

Symbol DOK7
Full Name Docking Protein 7
Gene Type Protein coding
Chromosomal Location 4p16.3
NCBI Gene ID 285489 ncbi.nlm.nih.gov/gene/285489
Ensembl ID ENSG00000138650
UniProt ID Q6IB77
OMIM ID 610285
HGNC ID 26594
Aliases CMS1B, FLJ45717, MGC131895

Description

The DOK7 gene encodes docking protein 7, a cytoplasmic adaptor protein essential for the formation and maintenance of the neuromuscular junction (NMJ). DOK7 interacts with the muscle-specific kinase (MuSK) to initiate and stabilize acetylcholine receptor clustering at the postsynaptic membrane. Mutations in DOK7 are a common cause of congenital myasthenic syndrome (CMS), particularly the limb-girdle type, and can also be associated with other neuromuscular disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital Myasthenic Syndrome 1B (CMS1B) Loss-of-function mutations in DOK7 impair MuSK activation and AChR clustering, leading to defective neuromuscular transmission. ClinVar, OMIM
Congenital Myasthenic Syndrome with Tubular Aggregates DOK7 mutations disrupt NMJ maintenance, causing muscle weakness and tubular aggregates on biopsy. OMIM, PubMed
Myasthenia Gravis (seronegative) Rare DOK7 variants may contribute to autoimmune-negative myasthenic phenotypes. ClinVar, COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal Muscle 12.5 Medium
Heart 8.3 Low
Brain 3.1 Low
Liver 0.9 Not detected
Kidney 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
RD (rhabdomyosarcoma) 15.0 Highest expression among tested lines
SH-SY5Y (neuroblastoma) 6.2 Moderate expression
HeLa (cervical carcinoma) 2.1 Low expression
HepG2 (hepatocellular carcinoma) 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1124_1127dupTGCC Duplication ~30% of CMS1B cases Frameshift, loss of function
c.1327C>T (p.Arg443*) Nonsense ~10% of CMS1B cases Premature stop, loss of function
c.331G>A (p.Gly111Arg) Missense Rare Impaired MuSK binding, loss of function
c.1393G>A (p.Gly465Arg) Missense Rare Reduced protein stability, loss of function
Mutation functional classification

Loss of Function (LOF)

Most DOK7 mutations are loss-of-function, leading to reduced or absent protein expression or impaired interaction with MuSK, resulting in defective neuromuscular junction formation and congenital myasthenic syndrome.

Gain of Function (GOF)

No gain-of-function mutations have been reported for DOK7.

Dominant Negative (DN)

Some missense mutations (e.g., p.Gly111Arg) may exert a dominant-negative effect by interfering with wild-type DOK7 function, though evidence is limited.

Pathways

Agrin-MuSK-DOK7 signaling in neuromuscular junction formation (Reactome: R-HSA-6794362)
DOK7-mediated AChR clustering (KEGG: hsa04730)

Protein Summary

Docking protein 7 (DOK7) is a 504-amino-acid cytoplasmic adaptor protein containing a pleckstrin homology (PH) domain and a phosphotyrosine-binding (PTB) domain. It is predominantly expressed in skeletal muscle and localizes to the postsynaptic membrane of the neuromuscular junction. DOK7 binds to the intracellular region of MuSK, promoting its autophosphorylation and downstream signaling that leads to acetylcholine receptor clustering. Loss of DOK7 function results in impaired NMJ formation and congenital myasthenic syndrome.

Related Products

Product name Cat.No. Species Gene ID
DOK7 Knockout HEK293 Cell Line EDJ-KQ13199 Human 285489 Details Get a Quote
DOK7 Knockout HeLa Cell Line EDJ-KQ41339 Human 285489 Details Get a Quote
DOK7 Knockout A-549 Cell Line EDJ-KQ67984 Human 285489 Details Get a Quote
DOK7 Knockout HCT 116 Cell Line EDJ-KQ76360 Human 285489 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: